BioSpace News Archive

Catalyst OrthoScience Inc., a medical device company focused on the upper extremity orthopedics market, will be at the American Academy of Orthopedic Surgeons 2022 Annual Meeting, March 23-25, 2022, in Chicago.

M-Squared Consulting, a consultancy company for life sciences companies in the management of pharmaceutical contracts, has received a first positive signal from EMA’s Pandemic Task Force in the Rapid Scientific Advice1 procedure for potential treatments for Covid-19 in the repositioning project for cyclobenzaprine, a drug for the treatment of acute musculoskeletal conditions.

Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by repurposing existing molecules for novel combination therapy, has entered a strategic partnership with KVK Tech.

Artelo Biosciences, Inc. announced it has been invited to present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT.

Indegene, a technology-led global healthcare solutions provider, and metaMe Health, Inc. (metaMe), a Prescription Digital Therapeutics (PDT) company and developer of Regulora®, today announced a partnership to bring Regulora to market for the treatment of abdominal pain due to Irritable Bowel Syndrome (IBS).

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the IVC procedure it enables, announced today that Inger Britt Carlsson, PhD, INVO Bioscience’s Vice President of Medical Affairs, will participate in a roundtable discussion at the 2022 Virtual Growth Conference.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that it is expanding its mRNA pipeline with two new development programs.

Ecolab Inc. has increased its portfolio of Alliance for Water Stewardship (AWS) certified sites, adding two manufacturing plants in Lerma and Cuautitlan Izcalli, Mexico.

Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), announces the following patent notifications and awards relating to the Company’s three lead drug candidates.

Decibel Therapeutics announced that Laurence Reid, Ph.D., Chief Executive Officer of Decibel, will participate in the following upcoming virtual investor conferences in March.